Sentien Biotechnologies, Inc. is a cutting-edge biotech company based in Lexington, MA, dedicated to restoring balance to the immune system through innovative cell therapies. Their groundbreaking SBI-101 technology allows for sustained and controlled dosage of therapeutic molecules, overcoming the limitations of conventional cell therapy methods. With a focus on treating dysregulated immune systems, including severe cases of COVID-19, Sentien Biotechnologies aims to transform cell therapy treatment and unlock the vast therapeutic potential of MSCs.
Driven by a mission to revolutionize healthcare, Sentien Biotechnologies is at the forefront of developing novel therapeutics for acute conditions characterized by systemic inflammation. Through their research and clinical trials, they strive to provide effective solutions for patients in need. With a commitment to attracting top scientific and commercial talent, Sentien Biotechnologies invites individuals to join their team and contribute to their quest for restoring immune system balance and advancing cell therapy treatment.
Generated from the website